Moody’s Upgrades American Realty Capital Trust’s Issuer Rating to ‘Ba2’; Outlook is Stable
05 Abril 2012 - 7:00PM
Business Wire
American Realty Capital Trust, Inc. (“ARCT” or the “Company”)
announced today it has been upgraded to a ‘Ba2’ credit rating with
a stable outlook by Moody’s Investor Service (“Moody’s”).
“We are pleased that Moody’s has upgraded the ratings of ARCT to
‘Ba2,’ with a stable outlook,” observed William M. Kahane, Chief
Executive Officer of ARCT. “This upgrade reflects our recent
listing on NASDAQ, the growth in our asset base, the reduction of
our effective leverage and secured debt levels, while maintaining
solid fixed charge coverage. The ratings upgrade further takes into
account the internalization of our management structure and
obtaining a $200 million term loan.”
Mr. Kahane added, “Our 2012 earnings guidance, announced on
March 30, 2012, estimated annualized FFO and AFFO for the 12-month
period commencing April 1, 2012, to range between $0.79 and $0.82
per share. This earnings outlook did not take into account the
ratings upgrade.”
As described by Moody’s press release dated April 5, 2012, “The
stable outlook reflects Moody’s expectation that ARCT will continue
to grow in a disciplined manner while improving its credit metrics
and maintaining adequate liquidity.” The details of Moody’s press
release can be viewed on the Company’s website at
www.arctreit.com.
Important Notice
This press release is for informational purposes only and is not
an offer to buy or the solicitation of an offer to sell any shares
of the Company.
American Realty Capital Trust, Inc., a publicly traded Maryland
corporation listed on The NASDAQ Global Select Market, is a leading
self-administered real estate company that owns and acquires single
tenant free standing commercial real estate properties that are
primarily net leased on a long-term basis to investment grade
credit rated and other creditworthy tenants.
The statements in this press release that are not historical
facts may be forward-looking statements. These forward looking
statements involve risks and uncertainties that could cause the
outcome to be materially different.
Additional information about the Company can be found on the
Company’s website at www.arctreit.com.
Arcturus Therapeutics (NASDAQ:ARCT)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Arcturus Therapeutics (NASDAQ:ARCT)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024